Treatment and prognosis in sinonasal mucosal melanoma: A retrospective analysis of 65 patients from a single cancer center
Authors:
- 30 July 2013
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 36 (5) , 675-681
Abstract
Background The purpose of this study was to evaluate the outcome in sinonasal mucosal melanoma (SMM). Methods A retrospective analysis of clinicopathological data from January 1976 to December 2005 was performed. Survival curve, univariate, and multivariate analyses were undertaken. Results Sixty‐eight patients with SMM were enrolled; 3 patients refused treatment. The 3‐year and 5‐year overall survival (OS) rates in the remaining 65 cases of SMM were 36.5% and 29.7%, respectively. Patients who underwent surgery had better 3‐year and 5‐year OS rates than those treated without surgery (40.7% and 34.1% vs 21.4% and 14.3%, respectively), and the same was true for patients treated with and without biotherapy (58.2% and 50.9% vs 30.0% and 23.4%, respectively). Distant metastasis at presentation was associated with a worse prognosis. Those patients managed with multimodality treatment had better OS rates. Conclusion The prognosis in SMM is poor, particularly for those with distant metastasis or without surgery. Multimodality treatment may improve survival. © 2013 Wiley Periodicals, Inc. Head Neck 36: 675–681, 2014Keywords
This publication has 24 references indexed in Scilit:
- Demographics and treatment trends in sinonasal mucosal melanomaThe Laryngoscope, 2011
- ReviewMelanoma Research, 2011
- Predictors of Survival in Mucosal Melanoma of the Head and NeckAnnals of Surgical Oncology, 2011
- Management of mucosal melanomas of the head and neck: did we make any progress?Current Opinion in Otolaryngology & Head and Neck Surgery, 2010
- Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanomaOral Oncology, 2008
- Biochemotherapy in patients with advanced head and neck mucosal melanomaHead & Neck, 2008
- Head and neck mucosal melanoma: Experience with 42 patients, with emphasis on the role of postoperative radiotherapyHead & Neck, 2008
- Phase II study of temozolomide plus pegylated interferon‐α‐2b for metastatic melanomaCancer, 2006
- Postoperative radiotherapy for primary mucosal melanoma of the head and neckCancer, 2005
- Primary mucosal melanoma of the head and neckCancer, 2004